Shanghai Junshi Biosciences Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,433.00
-2,686.00
-3,030.00
-658.00
-1,875.00
-866.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-575.00
-72.00
788.00
-33.00
75.00
-517.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1,496.00
-2,098.00
-1,997.00
-690.00
-1,613.00
-1,303.00
Cash Flow from Investing Activities
-1,024.00
-1,144.00
-344.00
-1,271.00
-854.00
-1,113.00
Cash Flow from Financing Activities
1,107.00
783.00
5,132.00
2,134.00
4,959.00
671.00
Net Cash Inflow / Outflow
-1,400.00
-2,451.00
2,898.00
144.00
2,439.00
-1,749.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
13.00
8.00
107.00
-27.00
-51.00
-4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Junshi Biosciences Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-1433.91955067647
1127.62207024831
-2,560.00
-227.16%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-575.760643760089
-1096.26089560387
521.00
47.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1496.50043280198
110.26014366349
-1,606.00
-1457.25%
Cash Flow from Investing Activities
-1024.45203438496
1062.88198038853
-2,086.00
-196.38%
Cash Flow from Financing Activities
1107.6910096616
291.389494568425
816.00
280.14%
Net Cash Inflow / Outflow
-1400.23489722896
1499.51410089885
-2,899.00
-193.38%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
13.0265602963842
34.9824822784042
-21.00
-62.76%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 28.69% vs -5.06% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-1,496.50
-2,098.54
28.69%






